Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2021 View
Thermo Fisher Scientific Inc.'s TMO second-quarter 2021 adjusted earnings per share of $5.60 beat the Zacks Consensus Estimate by 1.6%. The figure surged 43.9% year over year. The adjusted number excludes certain non-recurring expenses including asset amortization and restructuring costs.
GAAP earnings per share were $4.61, a 58.9% surge on a year-over-year basis.
The company’s organic growth in base business along with COVID-19 led initiatives to scale up vaccine production contributed to a strong bottom-line performance.
Revenues in the quarter under review grossed $9.27 billion, up 34% year over year.
...
https://finance.yahoo.com/news/thermo-fi...02607.html
Thermo Fisher Scientific Inc.'s TMO second-quarter 2021 adjusted earnings per share of $5.60 beat the Zacks Consensus Estimate by 1.6%. The figure surged 43.9% year over year. The adjusted number excludes certain non-recurring expenses including asset amortization and restructuring costs.
GAAP earnings per share were $4.61, a 58.9% surge on a year-over-year basis.
The company’s organic growth in base business along with COVID-19 led initiatives to scale up vaccine production contributed to a strong bottom-line performance.
Revenues in the quarter under review grossed $9.27 billion, up 34% year over year.
...
https://finance.yahoo.com/news/thermo-fi...02607.html
__________________